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Abstract
Background: Chronic kidney disease (CKD) is a condition of high prevalence in the general population mainly due
to hypertension and diabetes mellitus. It is often associated with a high prevalence of complications and worse
quality of life. The main objective of this study is to evaluate quality of life (QOL) using the generic instrument
SF-36 in patients with CKD in pre-dialysis and identify the possible influence of the degree of renal function,
hemoglobin level, age, gender, family income and level of education on QOL.
Methods: A cross-sectional study was conducted and included 170 individuals (83 men) with a mean age of
57 ± 15 years who met the inclusion criteria and answered the SF-36. Laboratory tests and clinical and demographic
data were obtained, and the glomerular filtration rate was estimated using the CKD-EPI formula.
Results: The degree of renal function did not influence QOL. Women had lower scores in functional capacity, physical
aspects, pain, and mental health. Patients younger than 47 years old showed better QOL in the functional capacity;
however, their QOL was worse in terms of social aspects. Subjects with an income higher than 5.1 times the minimum
wage had better QOL in the functional capacity, pain, social, physical and emotional roles, and mental health.
Hemoglobin levels and education did not globally influence QOL.
Conclusion: Gender and age influenced QOL, but family income was the most important factor affecting QOL (6 out
of 8 domains investigated by SF-36) in this sample of 170 individuals with CKD in pre-dialysis. These findings suggest
that many efforts should be made to reduce the effect of these factors on quality of life in patients with CKD and
reinforce the need for longitudinal studies and intervention.
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Background
The prevalence of chronic kidney disease (CKD), defined
by reduced glomerular filtration rate (GFR) and/or pres-
ence of proteinuria [1], is increasing worldwide due to
an aging population and a global epidemic of diabetes
[2]. In its final evolutionary stage, there is the need for
permanent dialysis or a kidney transplant, which leads to
very high health care costs for many countries.
Also, as described in previous work, CKD increases
cardiovascular risk [3, 4] and leads to loss of quality of
life in terms of health [5–9].
Hence, some studies have shown that quality of life
(QOL), assessed by internationally validated question-
naires, is worse in individuals with CKD compared to
those without renal disease [10], and that the morbidity
and mortality in end-stage disease are influenced by tim-
ing and quality care before the start of dialysis [8, 11]. A
systematic review of the QOL scores of these patients as
a parameter of treatment adequacy is recommended [1]
and it is also suggested that interventions in pre-dialysis
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are useful and can influence the clinical evolution in the
later stages of the disease [1, 8].
However, information on the QOL of patients under-
going conservative CKD treatment and the socio-
demographic factors that may influence QOL is limited.
The present study aims to assess the QOL of pre-
dialysis CKD patients by means of the SF-36, and to inves-
tigate the possible influence of CKD staging, hemoglobin,
age, family income, gender, and educational level on the
QOL of these individuals.
Methods
This is a cross-sectional study of outpatients with pre-
dialysis CKD monitored at Hospital Universitário de
Brasilia (HUB) and Hospital de Base do Distrito Federal
(HBDF) conducted from February 2011 to November
2012 (20 months).
Inclusion criteria were: 1) Having been diagnosed with
CKD, 2) Not having undergone a kidney transplant, 3)
Aged over 18 years; 5) agreeing to participate in the
study by signing a consent form.
Exclusion criteria were: 1) Neurological disorders that
may affect the implementation of tests; for instance, a
cerebrovascular accident (CVA); 2) Degree of literacy
and inability to understand the research objectives, 3)
Patients with comorbidities such as active cancer, infec-
tious or inflammatory diseases; 4) Mini-Mental State
Examination (MMSE) score lower than 14.
On the day of the interview, the participants’ socio-
demographic data were obtained, including name, ad-
dress, phone number, age, gender, level of education,
family income, race, comorbidities (diseases that accom-
pany CKD), etiology of CKD, current occupation, leisure
activities, weight, height, body mass index (BMI), con-
tinuous use medication, list of symptoms, blood pressure
(BP), and laboratory tests. We also recorded the know-
ledge of CKD patients about the disease and outpatient
follow-up time.
Their cognitive function was assessed by means of the
Mini Mental test, which is reliable and valid and is a
broad measure of the global cognitive status based on
the Mini-Mental State Examination (MMSE) [12]. It in-
cludes assessment guidance (range = 0–10), registration
and digit span (range = 0–13), attention and calculation
(range = 0–7), general knowledge (range = 0–5), recovery
(range = 0–3), language (range = 0–17), and construction
(range = 0–2) [12].
Later, to assess QOL, the SF-36 questionnaire (Medical
Outcomes Study 36 – Item Short – Form Health Survey),
translated and validated for the Portuguese language, [17]
was used. This questionnaire was chosen for its reli-
ability, frequency of use and ease of application. It
consists of 36 items divided into eight dimensions:
physical functioning (ten items), physical function
(four items), emotional function (three items), social
function (two items), emotional well-being (five items),
pain (two items), energy/fatigue (four items), and general
health (five items) [13]. Some domains assess the physical
aspect while others evaluate the mental aspect, and this
yields the physical (PS) and mental health (MS) summary
scales.
Data were collected from patients of both genders,
considering the inclusion and exclusion criteria. We in-
vited 185 individuals who met the inclusion criteria. Out
of these, five interrupted the interview and did not
complete the SF-36, four did not agree to sign the con-
sent form, three had been diagnosed with comorbidities
listed in the exclusion criteria and three obtained a mini-
mental score lower than 14. One hundred and seventy pa-
tients completed the study. Disease staging was done
through the estimated GFR calculated from serum creatin-
ine using the CKD-EPI equation [14] and CKD was classi-
fied according to the National Kidney Foundation [1].
Data collection began only after approval of the re-
search by the Ethics Research Committee of the College
of Medicine, University of Brasilia, and it was carried
out by a single interviewer. This research offered no
risks to participants and all patients gave written in-
formed consent to participate.
Blood samples collected at 12-hour fasting determined
concentrations of creatinine, urea, hemoglobin, total
cholesterol (TC), high density lipoprotein (HDL), low
density lipoprotein (LDL), triglycerides, C reactive pro-
tein (CRP), calcium, phosphorus, parathyroid hormone
(PTH), glucose, sodium, potassium, and uric acid.
The 10-year cardiovascular risk (Framingham risk
score) was calculated [4].
Statistical analysis
A priori, a minimum number of 160 patients was estab-
lished, assuming the effect size “f” of 0.25 for the outcome,
which represents a moderate effect, considering five ana-
lysis groups, plus 70 % power and a value of α equal to 5 %.
The normality of each continuous variable was evalu-
ated by visual observation of each quantile-quantile
graph (Q-Q plot); normal distribution occurs if the
points formed by the sample quantiles are aligned on a
straight slope.
Continuous variables are presented as mean ± standard
deviation (SD) and categorical variables as percentages.
The “t” test and the Pearson correlation test were used
to search for possible correlations between the different
parameters observed and the domains of SF-36. Gender,
age, level of education, income, and hemoglobin were
associated with different QOL domains, being candidates
for a multivariate analysis (MANCOVA). CKD staging
was included in the analysis due to its influence on QOL
in previous studies.
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Considering the assessment of QOL as a combination
of all the different domains of SF-36, a MANCOVA was
performed. It had as dependent variables the 8 domains
of SF-36 and as independent variables CKD staging, age,
gender, income, level of education, renal function, and
hemoglobin, one at a time. The analysis was also con-
trolled for gender and age.
The MANCOVA was used along with Wilks’ lambda
test to evaluate the relationship among variables. Two
conditions for the analysis were observed: if the data for
each dependent variable (SF-36) were normally distrib-
uted; if Box’s “M” test indicated there was no violation
of the homogeneity assumption of the variance-
covariance matrices. The SF-36 domains were consid-
ered dependent variables and age, gender, CKD staging,
level of education, income, and hemoglobin, one at a
time, were considered explanatory variables. Gender plus
age were considered covariates.
Continuous explanatory variables were turned into
categorical variables as a requirement for the MAN-
COVA. Thus, hemoglobin was divided into three cat-
egories: less than or equal to 9 g/dL; greater than or
equal to 13 g/dL; between 13 and 9 g/dl g/dL. Similarly,
the limits of 47 and 60 years (25th and 50th percentiles,
respectively) were used for age; for income, values from
1 to 5 minimum wages were considered; in terms of
level of education, values from 3 to 11 years were used.
The SPSS software version 20 was used to assess the
data. P < 0.05 was considered statistically significant.
Results
The study included a sample of 170 CKD patients aged
57.38 ± 15.74 (mean ± SD), out of these, 51 % were fe-
male and 55 % white. Most of them had a partner; only
39 % were single, separated and/or widowed. In terms of
level of education, there was a variation from 0.5 to
20 years of study; 55 % of subjects had studied at least 5
or more years. Family income averaged 3.34 times the
minimum wage; the maximum value was 10 minimum
wages and the minimum, 1; interquartile range was 5-1
and standard deviation, 2.33.
When participants were asked about the triggering
factor of CKD, 30.58 % of them did not know what it
was. In this case, the information was obtained from
medical records and it was also used to confirm the pa-
tients’ report. Among the associated diagnoses, hyper-
tension (HBP) (88 %) and diabetes mellitus (DM) (31 %)
were found, and most diabetics were also hypertensive.
The average weight was 69.65 kg (±16.57), height was
1.61 m2 (± 0.09), body surface area of 1.75 m2 (± 0.22),
and Body Mass Index (BMI) of 26.35 kg/m2 (± 5.81). Fa-
tigue, cramps and nausea were, respectively, the most
frequently reported complaints. Most individuals were
sedentary (62.94 %), but they had a leisure activity
(61.76 %) and had been in outpatient medical care for
more than one year (65.29 %). The 10-year cardiovascu-
lar risk, according to the Framingham risk score, was
higher for men, and 40.58 % showed intermediate to
high risk.
Table 1 shows the overall average of laboratory tests,
BMI, Systolic Blood Pressure (SBP), Diastolic Blood
Pressure (DBP), age, cardiovascular risk (framingham
risk), family income and staging of the 170 individuals
according to gender.
According to the estimated value of GFR from serum
creatinine and the use of the CKD-EPI formula, the
interviewed participants were in stages I/II (n = 18), III
(n = 56), IV (n = 64) and V (n = 32). As their renal function
deteriorated, from the initial stages to stage V, it was ob-
served that hemoglobin significantly decreased, and phos-
phorus, potassium, uric acid and PTH increased.
Table 1 Anthropometrics, physical data, cardiovascular risk,




N = 83 N = 87
Age (years) 61.19 ± 14.89 53.74 ± 15.74 0.002
BMI (kg/m2) 26.39 ± 5.12 26.44 ± 5.84 0.945
SBP (mmHg) 131.81 ± 24.25 130.17 ± 26.30 0.672
DBP (mmHg) 82.56 ± 15.35 80.00 ± 13.16 0.243
Framingham risk 13.90 ± 8.96 5.73 ± 6.10 <0.001
GFR (ml/min/1.73 m2) 33.39 ± 18.75 30.94 ± 20.80 0.422
Creatinine (mg/dL) 2.75 ± 1.82 2.62 ± 1.80 0.643
Hemoglobin (g/dL) 13.39 ± 2.06 12.08 ± 1.82 <0.001
Total cholesterol (mg/dL) 184.01 ± 47.72 203.52 ± 47.74 0.009
HDLc (mg/dL) 40.25 ± 15.53 46.24 ± 14.20 0.012
LDLc (mg/dL) 107.75 ± 41.73 120.54 ± 45.25 0.076
Triglycerides (mg/dL) 172.88 ± 91.43 170.68 ± 118.73 0.897
Calcium (mg/dL) 9.05 ± 1.11 9.13 ± 0.65 0.576
Phosphorus (mg/dL) 4.04 ± 1.10 4.24 ± 0.96 0.240
PTH (pg/mL) 140.35 ± 208.90 236.93 ± 259.81 0.080
Proteinuria (mg/day) 91.63 ± 164.62 97.27 ± 237.38 0.928
Glucose (mg/dL) 99.33 ± 29.96 101.00 ± 27.52 0.714
Sodium (mEq/L) 137.75 ± 7.26 139.54 ± 3.32 0.043
Potassium (mEq/L) 4.65 ± 0.85 4.61 ± 0.65 0.735
Uric acid (mg/dL) 7.53 ± 1.92 6.90 ± 1.54 0.026
Ferritin (ug/L) 164.78 ± 189.67 260.03 ± 368.29 0.138
Income (minimum wage) 3.88 ± 2.21 2.81 ± 2.26 0.002
BMI Body Mass Index, SBP Systolic Blood Pressure, DBP Diastolic Blood
Pressure, eGFR estimated glomerular filtration rate (CKD-EPI), TC total
cholesterol, HDLc high density lipoprotein cholesterol, LDLc low density
lipoprotein cholesterol, PTH parathyroid hormone
#T test
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With regard to gender, women were younger (53.74 ±
15.74 versus 61.19 ± 14.89, p = 0.002), had reduced
hemoglobin, lower uric acid and higher TC, HDL and
sodium and had lower family income (2.81 ± 2.26 versus
3.88 ± 2.21, p = 0.002) than men.
Table 2 shows the dimensions of the SF-36 obtained
from the 170 patients with CKD according to gender-
adjusted estimates by age. It shows that gender influ-
enced QOL. The men with CKD in this study had a bet-
ter quality of life than women. Men with CKD had
better functional capacity, mental health, pain domain
and physical aspects.
As summarized in Table 3, there was no difference in
QOL among the 5 stages of CKD in pre-dialysis.
Table 4 shows that the influence of hemoglobin on
QOL was observed only in the social aspects domain,
which was significantly lower in CKD patients who had
hemoglobin less than or equal to 9 g/dl.
Age influenced the QOL of CKD patients in the func-
tional capacity and social aspects domains. Functional
capacity was better in CKD patients aged less than
47 years. The social aspect was better in the elderly
compared to young people aged up to 47 years (Table 5).
As detailed in Table 6, income had a major influence
on QOL; 6 out of 8 domains investigated by the SF36
were influenced by it. In this sample, CKD patients with
an income greater than 5.1 times the minimum wage
had better QOL in terms of physical functioning, pain
and social aspects than those who earned only one mini-
mum wage. Physical and emotional role and mental
health were also better in those whose income was
greater than 5.1 times the minimum wage.
Level of education did not influence QOL (Table 7).
However, in isolation, CKD patients who had over
11 years of study had better physical functioning than
those who had studied for three years at most.
Discussion
Chronic kidney disease is a serious public health issue,
and the affected patients have a poor quality of life from
the early stages to the evolution to dialysis or kidney
transplantation. Quality of life measurement is increas-
ingly recognized as an important tool to assess progress
and determine which intervention measures can lead to
better well-being and success in treatment. Several stud-
ies have shown that quality of life is impaired in chronic
kidney disease at its various stages of treatment. In
addition, psychological factors, anxiety, depression and
alexithymia may be related to treatment complications
and lower quality of life in chronic renal failure patients
[15–17]. Patients undergoing kidney transplant appear
to have better quality of life than those who are on dialy-
sis, despite suffering the effect of the use of immunosup-
pressive drugs and being subject to infectious
complications and tumors [18]. Conversely, patients in
the pre-dialysis stage, despite not being dependent on
the machine or dialysis, suffer from various comorbidi-
ties such as anemia, mood swings and social condi-
tions that may interfere with treatment and their well-
being, which, in turn, affect their quality of life. The
results of this study indicate that, among the factors
investigated, sex (p = 0.016), age (p = 0.011) and family
income (p = 0.017) influenced the quality of life of pa-
tients with CKD. Also, CKD severity did not impact
the various domains of SF-36 (p = 0 961) in unex-
pected ways.
As expected, symptoms resulting from complications
and comorbidities are more common as kidney disease
progresses, resulting in lower scores of quality of life.
One explanation for the results observed in this study
regarding the little influence of disease staging on quality
of life is the small number of patients in each stage of
the disease. The difference in QOL among the stages of
CKD was more frequently identified in studies of a large
number of individuals, generally over 1000 [10]. None-
theless, socio-demographic variables were predictors of
QOL even in cross-sectional studies that involved fewer
than 1000 subjects.
In this study, the physical dimension was the most af-
fected in CKD, as compared to the mental domains.
These results are consistent with those of previous stud-
ies that also showed that the physical aspects of CKD
patients are more affected in terms of QOL [8, 19].
Physical functioning was better in CKD patients aged
less than 47 years, and the social aspect was better in
the elderly as compared to young individuals aged up to
47 years. A younger age has been associated with a
greater decline in mental health and emotional role, but
Table 2 Different domains of SF-36 obtained from 170 patients
with CKD considering gender adjusted by age
Gender#
Domains SF-36 Female Male Total P*
N = 87 N = 83 N = 170
Functional
capacity
49.08 (± 28.34) 57.10 (± 26.12) 52.99 (± 27.49) 0.018
Physical aspects 38.89 (± 37.28) 51.20 (± 38.23) 44.90 (± 38.14) 0.040
Pain 55.51 (± 27.55) 65.77 (± 28.28) 60.52 (± 28.30) 0.025
General health 54.08 (± 25.87) 54.80 (± 26.13) 54.43 (± 25.92) 0.923
Vitality 53.68 (± 24.16) 60.12 (± 21.89) 56.82 (± 23.24) 0.090
Social aspects 74.89 (± 27.68) 77.14 (± 27.93) 75.99 (± 27.75) 0.935
Emotional
aspects
50.58 (± 43.12) 54.71 (± 38.01) 52.60 (± 40.64) 0.552
Mental health 60.25 (± 23.61) 69.54 (± 22.15) 64.79 (± 23.31) 0.017
#P = 0.016 (Wilks’ Lambda)
*Mancova
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with better physical functioning and general health [20].
Another research study found worse mental health in
the youngest age group and worse physical functioning
in the oldest age group [21]. Therefore, our results are
similar to findings from other studies which identified
worse physical performance but better mental health in
older people [22]. A suggestion for these two groups
would be to raise their awareness about the disease,
making it more tolerable both physically and emotionally
for patients and their families [16].
Men with CKD in this sample had higher income and
higher hemoglobin, and this could explain their better
QOL in terms of physical functioning, mental health,
and pain in relation to women. This was in agreement
with another study which showed that men and individ-
uals with a higher income had better mental health [22].
Men obtained significantly higher scores in all scales
(except physical role), including PS (Physical Summary)
and MS (Mental Health Summary), while women had
the worst QOL [19]. These findings may be explained by
the fact that women are more prone to suffering from
depression [15, 16], they experience greater pain in
chronic diseases [20], and take on greater responsibility
to adapt their lives to their new CKD reality [23].
Men with CKD had a higher 10-year cardiovascular
risk as compared to women, probably because they were
older.
In this study, the level of hemoglobin (Hb) showed no
significant differences in terms of QOL, despite having
negatively influenced the social aspect when below 9 g/dl.
Other findings indicated that the severity of anemia had a
modest effect on QOL [20, 24-26]. One possible explan-
ation for this discrepancy may be that the majority of our
sample had more than one year of outpatient follow-up
and Hb > 11 g/dL [27, 28].
Level of education did not significantly influence
QOL. However, CKD patients with more than 11 years
of education had better physical functioning than those
who had studied for three years at most. The lack of
statistical significance for the relationship between level
of education and QOL could be explained by the results
of similar studies which found a greater PS in individuals
Table 3 Different domains of SF-36 obtained from 170 patients with CKD considering CKD staging adjusted by gender and age
Stages
Domains SF-36 TFG > 90 Mild Moderate Severe Terminal Total P*
N = 3 N = 15 N = 56 N = 64 N = 32 N = 170
Functional capacity 75.00 (±26.45) 45.33 (±24.74) 52.32 (±27.91) 55.22 (±28.12) 51.25 (±26.85) 52.99 (±27.49) 0.546
Physical aspects 83.33 (±28.86) 38.33 (±41.04) 49.11 (±37.52) 41.53 (±37.01) 43.75 (±40.16) 44.9 (±38.14) 0.300
Pain 66.33 (± 30.60) 54.53 (± 22.53) 66.07 (± 30.71) 58.12 (± 29.39) 57.84 (± 23.49) 60.52 (± 28.30) 0.542
General health 63.00 (±37.32) 45.27 (±22.16) 56.39 (±26.62) 55.16 (±27.50) 53.03 (±22.37) 54.43 (±25.92) 0.637
Vitality 65.00 (±25.98) 51.00 (±23.69) 57.77 (±23.89) 56.25 (±23.68) 58.28 (±21.61) 56.82 (±23.24) 0.762
Social aspects 100.00 (±0.00) 71.63 (±27.74) 79.00 (±29.67) 75.28 (±27.10) 71.94 (±26.38) 75.99 (±27.75) 0.402
Emotional aspects 88.90 (±19.22) 47.35 (±47.85) 58.33 (±38.84) 49.47 (±40.33) 47.88 (±41.47) 52.60 (±40.64) 0.357
Mental health 69.33 (±32.5) 62.53 (±25.79) 65.80 (±25.00) 63.91 (±23.04) 65.41 (±19.95) 64.79 (±23.31) 0.934
*P = 0.961 (Wilks’ Lambda)
Mancova
Table 4 Different domains of SF-36 obtained from 170 patients with CKD considering hemoglobin (Hb) adjusted by gender and
age
Level of hemoglobin*
SF-36 domains Hb≤ 9.0 Hb 9.1–12.9 Hb≥ 13 Total P#
N = 12 N = 56 N = 93 N = 161
Functional capacity 46.67 (± 31.50) 48.51 (± 26.90) 56.28 (± 27.13) 52.99 (± 27.49) 0.166
Physical aspects 33.33 (± 34.23) 35.96 (± 35.98) 51.32 (± 38.74) 44.90 (± 38.14) 0.072
Pain 46.25 (± 27.30) 59.56 (± 26.51) 62.75 (± 29.11) 60.52 (±28.30) 0.270
General health 46.42 (± 19.27) 57.96 (± 24.93) 53.39 (± 27.03) 54.43 (± 25.92) 0.315
Vitality 52.92 (± 20.83) 55.00 (± 24.23) 58.32 (± 23.02) 56.82 (± 23.24) 0.819
Social aspects 51.17 (± 29.39) 78.11 (± 23.48) 77.74 (± 28.59) 75.99 (± 27.75) 0.015
Emotional aspects 47.17 (± 38.89) 43.85 (± 40.94) 58.18 (± 40.09) 52.60 (± 40.64) 0.118
Mental health 54.67 (± 22.52) 66.39 (± 22.83) 66.78 (± 23.52) 64.79 (± 23.31) 0.424
*P = 0.057 (Wilks’ Lambda)
#Mancova
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with a higher level of education, but who were profes-
sionally active [22]. This did not occur in our research
study.
CKD patients with an income greater than 5.1 times
the minimum wage had better QOL in terms of physical
functioning, pain, social aspects, mental health, and
physical and emotional aspects, that is, they had better
QOL than those who had a monthly income inferior to
5.1 wages. Unemployment and low income [16] were
significantly associated with depression, which could ex-
plain the worse QOL found in our work. Depression
symptoms and worse socioeconomic conditions in CKD
patients have been associated with a worse QOL [29-31].
Research on end-stage renal disease patients has shown
that the severity of depression symptoms is also influ-
enced by monthly income [15].
Few studies have evaluated the influence of income on
QOL. Unemployment, a low level of education and low
income have been associated with worse QOL [19]. Em-
ployment, level of education, household income, physical
activity, and male gender were, independently, signifi-
cant predictors of PS. Employment, age and male gender
were predictors of MS [19]. In a cross-sectional study,
unemployment was associated with a worse QOL, and
better social support and coping skills with a better
QOL [31]. Another study found better mental health in
people with higher income [21]. Social support is a way
to offer better health care to end-stage renal disease pa-
tients [16]. In any case, a higher income may allow more
leisure time or better social support. In addition, vitality
in CKD patients on conservative treatment has already
been associated with the “going-out frequency” [32].
These results are consistent with the evidence that
socio-demographic factors are important predictors of
QOL in CKD patients.
In addition, renal disease is associated with dietary,
water and social restrictions, which make treatment ac-
ceptance difficult and may cause loss of QOL. It has
been observed that psychosocial factors such as finance
(69.3 %), logistics (66.0 %) and lack of social support
(17.0 %) negatively influence the acceptance of treatment
by CKD patients [33]. Moreover, CKD limits the ability
to work and increases the costs related to the disease,
and this also explains the worst QOL in patients with a
Table 5 Different domains of SF-36 obtained from 170 patients with CKD considering age adjusted by gender
Age (years)#
SF-36 domains ≤47 48–59 ≥60 Total P*
N = 43 N = 44 N = 83 N = 170
Functional capacity 61.28 (± 25.49) 46.36 (± 26.70) 52.22 (± 28.12) 52.99 (± 27.49) 0.015
Physical aspects 41.28 (± 35.72) 46.02 (± 41.74) 46.18 (± 37.70) 44.90 (± 38.14) 0.937
Pain 61.33 (± 25.05) 56.02 (± 26.14) 62.48 (± 30.91) 60.52 (± 28.30) 0.466
General health 54.23 (± 24.64) 48.98 (± 24.63) 57.42 (± 27.03) 54.43 (± 25.92) 0.224
Vitality 53.60 (± 21.63) 56.82 (± 22.90) 58.49 (± 24.29) 56.82 (± 23.24) 0.746
Social aspects 65.79 (± 26.75) 78.14 (± 26.07) 80.14 (± 28.09) 75.99 (± 27.75) 0.021
Emotional aspects 46.51 (± 39.99) 57.81 (± 42.49) 52.99 (± 40.05) 52.60 (± 40.64) 0.472
Mental health 60.49 (± 22.22) 67.20 (± 21.89) 65.73 (± 24.54) 64.79 (± 23.31) 0.555
#P = 0.011 (Wilks’ Lambda)
*Mancova
Table 6 Different domains of SF-36 obtained from 170 patients with CKD considering income adjusted by gender and age
Family income*
SF-36 domains Up to 1 minumum wage 1.1 to 5 minimum wages More than 5.1 minimum wages Total P#
N = 50 N = 77 N = 42 N = 169
Functional capacity 46.20 (± 27.63) 52.99 (± 26.63) 62.09 (± 27.30) 52.86 (± 27.52) 0.042
Physical aspects 32.00 (± 37.12) 42.64 (± 34.38) 63.89 (± 38.27) 44.57 (± 38.01) 0.001
Pain 54.46 (± 27.37) 59.13 (± 28.63) 71.38 (± 27.03) 60.28 (± 28.22) 0.029
General health 52.42 (± 24.08) 51.92 (± 26.89) 60.69 (± 25.26) 54.33 (± 25.96) 0.153
Vitality 53.10 (± 22.60) 56.82 (± 23.42) 61.22 (± 22.89) 56.75 (± 23.28) 0.465
Social aspects 66.99 (± 31.50) 77.49 (± 27.38) 84.23 (± 20.20) 75.85 (± 27.77) 0.013
Emotional aspects 39.97 (± 42.08) 49.77 (± 38.53) 71.35 (± 35.57) 52.32 (± 40.59) 0.001
Mental health 58.20 (± 23.91) 63.53 (± 22.66) 74.49 (± 20.41) 64.65 (± 23.31) 0.012
*P = 0.017 (Wilks’ Lambda)
#Mancova
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lower income. In CKD patients already in dialysis phase,
the physical component of QOL was greater in the
higher income group [34].
In this study, detailed information about the sources
of income showed that only a minority (28 %) still had a
job (professionally active) and 50.58 % had as a source of
income (which was not always exclusive) retirement or
disability insurance. In chronic renal patients undergoing
hemodialysis, we found low scores for aspects of QOL
associated with “job status”, “cognitive function”, and
“physical and emotional roles”, while high scores were
obtained in terms of “patient satisfaction”, “support from
the dialysis staff”, and “quality of social interaction” [35].
Greater attention to the level of habitual activity
among patients with CKD and ESRD could help these
individuals to keep their jobs, which could improve their
overall QOL [36]. Other studies have also strengthened
the relationship between a number of demographic char-
acteristics in QOL [19, 33], so much so that the need to
offer CKD patients on conservative treatment more op-
portunities for self-management has been investigated,
addressing issues related to social disadvantage [37].
The economic conditions of low-income families af-
fected by renal disease reinforce the interrelations be-
tween chronic disease, economic well-being and quality
of life in this population. However, since CKD is highly
interactive with multiple comorbidities, health costs for
these patients cannot be attributed solely to CKD. In-
deed, a financial policy for the pre-dialysis period can be
a suggestion for better results in terms of QOL [7].
Health assistance is a social right for all citizens and it
requires the direct and positive intervention of the State
in order to provide services for the diagnosis, treatment
and medical follow-up of diseases, including the im-
provement of patients’ QOL. Low-income patients de-
pend on public transportation to go to health units;
however, public transportation is not always reliable, and
this causes them stress and fatigue, jeopardizing the out-
patient follow-up of diseases. In addition, low-income
patients are more worried about the impact of the dis-
ease on production for survival, leading to family con-
flicts and the consequent development of comorbidities,
such as depression, which impact QOL. Leisure activities
are jeopardized for low-income patients. Previous studies
have already shown that functional independence, high-
income families and absence of depression are related to
better QOL [29, 30, 36]. In view of the fact that equity is
one of the universal principles of the national health sys-
tem in Brazil, it is suggested that relevant programs be
offered to the low-income population with chronic renal
disease.
Conclusions
In this study, a worse QOL was observed in CKD pa-
tients since the early stages of the disease, but a signifi-
cant relationship between CKD staging and the SF-36
domains was not identified. Gender and age influenced
QOL, but family income was the aspect that had the
most influence. These findings suggest that many efforts
should be made to reduce the effect of these economic
factors on the QOL of CKD patients. They also reinforce
the need for longitudinal and intervention studies of
pre-dyalitical CKD patients.
Limitations
The selected sample included only patients who were
already being monitored in specialized outpatient clinics,
and this limits the conclusions drawn based on the find-
ings to the population studied. The possible influence of
time and treatment on the evolution of QOL was not
evaluated longitudinally in this cross-analytical study.
Table 7 Different domains of SF-36 obtained from 170 CKD patients considering level of education and years of study adjusted by
gender and age
Years of study#
Domains SF-36 Up to 3 From 3,1 to 11 More than 11 Total P*
N = 49 N = 62 N = 57 N = 168
Functional capacity 45.92 (± 26.19) 51.94 (± 28.39) 60.26 (± 26.22) 52.64 (± 27.45) 0.128
Physical aspects 37.24 (± 38.56) 43.48 (± 35.37) 53.07 (± 39.82) 44.90 (± 38.14) 0.070
Pain 60.59 (± 28.37) 57.36 (± 28.35) 64.00 (± 28.26) 60.52 (± 28.30) 0.390
General health 55.12 (± 27.21) 52.77 (± 27.15) 55.70 (± 23.64) 54.43 (± 25.92) 0.604
Vitality 57.86 (± 24.10) 56.02 (± 23.65) 56.84 (± 22.37) 56.82 (± 23.24) 0.936
Social aspects 77.57 (± 29.06) 76.16 (± 28.49) 74.45 (± 26.10) 75.99 (± 27.75) 0.894
Emotional aspects 44.88 (± 41.74) 57.83 (± 39.99) 53.36 (± 40.11) 52.60 (± 40.64) 0.219
Mental health 62.78 (± 24.05) 62.75 (± 25.06) 68.81 (± 20.31) 64.79 (± 23.31) 0.147
#P = 0.244 (Wilks’ Lambda)
*Mancova
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